Services for TCR-T Cells - IND grade

TCR-T cells, or T cell receptor-engineered T cells, are a type of genetically modified immune cell used in immunotherapy by inserting the TCR chains that can specifically recognize the tumor antigen into T cells, particularly for cancer treatment. Apex specializes in offering comprehensive service solutions for cellular therapies. The company has developed a fully closed process development platform for cellular therapies, allowing it to deliver high-quality, customized services to clients with diverse needs in cell-based treatments.

Services

Advantages

Advantages of our Platform:

• Proprietary cryopreserved cell preparation

• Closed, automated culturing systems, aligned with global standards

• GMP-compliant facilities with B+A grades and unidirectional airflow

• Enhanced cell proliferation rates, improving growth and positive rates

• Flexible for various cellular therapies

• Extensive experience with automated culturing equipment

• Manufactured 200+ IIT clinical samples

• Successful TCR-T IND submission approved by NMPA

• Expertise in technology transfer and clinical cell sample manufacturing

Manufacturing Process

Quality Control